September 2026 corporate presentation. Retina focused company with THREE LATE-STAGE PROGRAMS built on the ABC Platform.
Kodiak at the 44th Annual J.P. Morgan Healthcare Conference, January 12, 2026. Three late-stage programs and 2026 CATALYSTS.
Kodiak at the Jefferies Global Healthcare Conference, June 2026, after POSITIVE GLOW2 PHASE 3 RESULTS.
Kodiak at the Jefferies Global Healthcare Conference, London, November 17, 2025, ahead of THREE PHASE 3 READOUTS in 2026.
APEX Phase 1b data for KSI-101, a BISPECIFIC IL-6/VEGF antibody, in MESI: meaningful vision gains and RAPID RETINAL DRYING.
